Bristol Myers Squibb

Tomorrow's Innovators is an initiative that builds a sustainable bridge for diverse talent from Historically Black Colleges and Universities (HBCUs) to the biopharma industry. Its conception is another step toward creating an equitable future for Black talent in healthcare.

Through collaboration with the HBCUs, Tomorrow’s Innovators will co-create custom biopharma programming, develop a 2-way leadership exchange program for collaboration and research purposes, increase HBCU talent recruitment, and attract executive-level Black talent. Together, we’ll build the incubator for the industry’s future leaders to create a more diverse and equitable future in healthcare.

Learn more: https://www.bms.com/tomorrows-innovators.html

For one week, every year, our employees assess the value of the work they do and its impact on patients.
Though there is always so much to celebrate during Global Patient Week, the week also reminds us that there is more to do.

While our commitment to serving our patients is unwavering, our work continues to evolve to ensure we can continue to have an impact on our patients, their families, and the communities we serve for years to come.

Bristol Myers Squibb is committed to sustaining a culture of inclusion that relies on the diversity of our people. Our People and Business Resource Groups (PBRGs) help us meet this commitment in a truly distinct way that impacts our business performance.

PBRGs are open to the entire global workforce. These groups focus on the Global Diversity & Inclusion priorities of workforce, workplace and marketplace to drive business results, foster an inclusive culture, and encourage employee engagement. These groups also provide opportunities for networking and continued professional growth and development.

We are committed to preserving natural resources, minimizing the environmental impact of our operations and reducing greenhouse gas (GHG) emissions.

To help reduce our greenhouse gas emissions, we support: Voluntary reporting of greenhouse gas emissions, funding energy efficiency and greenhouse gas reduction projects and implementing high efficiency & innovative technologies.

Track our progress at www.bms.com/about-us/sustainability.

We recognize our role in creating the change needed to address health disparities and racial inequality.

Bristol Myers Squibb and the Bristol Myers Squibb Foundation have announced a commitment to invest $300 million by 2025 to accelerate health equity and diversity and inclusion efforts. We will focus on 1) addressing health disparities, 2) increasing clinical trial diversity, 3) expanding our supplier diversity program, 4) expanding our U.S. Employee Giving Program and 5) increasing our workforce diversity.

Read our first diversity and inclusion report: https://www.bms.com/about-us/global-diversity-and-inclusion/diversity-and-inclusion-report.html

Bristol Myers Squibb recognizes COVID-19 has created unique challenges for each of us. We are focused on protecting our workforce’s health and safety, ensuring a continued supply of medicines to patients and supporting relief efforts across the globe. We will take all necessary actions to promote public health and carry out our mission of providing life-saving medicines to patients who depend on us.

We are will continue to serve the needs of our global patients with an uninterrupted supply of medicines, prioritize the health and safety of our employees with PPE, physical distancing and enhanced cleaning, and operate with the compassion and flexibility to address the individual needs of our workforce.